An interventional study of Pharyngeal width measurement in Sleep Apnea, Obstructive, sponsored by Inspire Medical Systems, Inc.. Recruiting at 10 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-17.
Sponsored by Inspire Medical Systems, Inc. · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc. — 5 open to participants now, 8 under way, none of them phase 3. Sleep Apnea, Obstructive · Inspire Medical Systems, Inc..
Among the 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc., this one is the only one that started in 2022, is one of 6 with no phase, and was the 9th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →5 of the 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc. are open now, in 8 countries. Recruiting first, the newest first:
Inspire Medical Systems, Inc. · Sites in United States
Ages 18+
Inspire Medical Systems, Inc. · Sites in Austria, Belgium, France and 4 more countries
Ages 18+
Inspire Medical Systems, Inc. · Sites in United States
Ages 13–18
Inspire Medical Systems, Inc. · Sites in United States
Ages 18–21
By country, each count listing its studies:
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2022.
This study's planned enrollment of 300 is above the median of 52 across 1,476 interventional studies indexed under Sleep Apnea, Obstructive.
Median enrollment 60 across the 9 interventional studies, 535 across the 4 observational. Of the 5 that completed or were terminated, 1 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
Inspire Medical Systems, Inc. is the lead sponsor of 13 studies on the registry; 5 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc., from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study is an exploratory, multicenter study of up to 300 subjects diagnosed with obstructive sleep apnea who are being evaluated for airway surgery. Subjects will undergo standard evaluation for airway surgery as part of standard of care. In addition to the standard airway assessment, a simple, non-invasive measurement of the width of the inside of each subjects mouth will be performed. This measurement takes 2-3 minutes to perform.
The objective of the study is to determine whether pharyngeal width (inside of the mouth) is an appropriate measurement to predict absence of complete concentric collapse (CCC) at the soft palate
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A simple, non-invasive measurement of the pharyngeal width inside each subjects mouth
Measurement of pharyngeal width to determine if there is correlation between pharyngeal width and presence or absence of complete concentric collapse at the soft palate during drug induced sleep endoscopy
Pharyngeal width will be measured in millimeters using a caliper
Time frame: Baseline, prior to routine diagnostic drug induced sleep endoscopy
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2022 to primary completion in Jan 2024, 20 months.
Of 118 industry-sponsored interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 20 months is above that.
Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Inspire Medical Systems, Inc.